Dec 27, 2011
Thank you to willbb for the information below regarding guidelines for treating with Victrelis (boceprevir) or Incivek (telaprevir).
Both boceprevir and telaprevir must not be administered as monotherapy and must be administered together with both pegIFN and RBV. If pegIFN or RBV is discontinued for any reason, boceprevir or telaprevir must also be discontinued. Boceprevir and telaprevir must not be dose reduced. Boceprevir and telaprevir must not be stopped and then restarted. The importance of adherence should be emphasized to patients to ensure the greatest potential for treatment success and to minimize potential for treatment failure and subsequent resistance development.